Regulatory woes of pharma SMEs (Part I)

Read more

Back to the roots —Landscaping OTC opportunities in the Indian ayurveda market

Read more

A holistic view of the HPAPI opportunity

Read more

Beyond the Ban

Read more

Sanofi ties up with Joslin Diabetes Center

Read more

Boehringer—Lilly alliance to launch first diabetes drug in India

Read more

CHMP recommends Novartis drug Afinitor for EU approval

Read more

Daiichi Sankyo and Ranbaxy launch hybrid business in Venezuela

Read more

COMP adopts recommendations for orphan designation

Read more

GoI bans use, import of blood test kits for TB

Read more